Buscar | Pikumil

Subodh Adke agregó una foto Networking
2026-05-05 11:46:01 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Commentarios 0 Acciones 668 Views 0 Vista previa

Please log in to like, share and comment!
Accrete Pharma agregó una foto Health
2026-10-15 08:31:18 -

Accrete Pharmaceuticals Private Limited – Bulk Drug Intermediates and Oncology Products
Accrete Pharmaceuticals Private Limited is a company based in India that works with medicines that fight cancer and with materials used to make those medicines, including Imatinib Intermediate. The company focuses on making sure that everything it produces is of quality and that it knows a lot about the products it sells. It also likes to make sure that customers are happy. The company helps...

0 Commentarios 0 Acciones 13 Views 0 Vista previa

Please log in to like, share and comment!